AdAlta Limited (1AD.AX)

AUD 0.02

(-6.25%)

Operating Expenses Summary of AdAlta Limited

  • AdAlta Limited's latest annual operating expenses in 2024 was 6.76 Million AUD , down -18.54% from previous year.
  • AdAlta Limited's latest quarterly operating expenses in 2024 FY was 6.99 Million AUD , down -15.78% from previous quarter.
  • AdAlta Limited reported a annual operating expenses of 8.31 Million AUD in annual operating expenses 2023, down -1.58% from previous year.
  • AdAlta Limited reported a annual operating expenses of 8.44 Million AUD in annual operating expenses 2022, down -9.37% from previous year.
  • AdAlta Limited reported a quarterly operating expenses of 2.81 Million AUD for 2024 Q4, down 0.0% from previous quarter.
  • AdAlta Limited reported a quarterly operating expenses of 4.07 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of AdAlta Limited (2024 - 2013)

Historical Annual Operating Expenses of AdAlta Limited (2024 - 2013)

Year Operating Expenses Operating Expenses Growth
2024 6.76 Million AUD -18.54%
2023 8.31 Million AUD -1.58%
2022 8.44 Million AUD -9.37%
2021 9.31 Million AUD -2.62%
2020 9.56 Million AUD 0.76%
2019 9.49 Million AUD 61.51%
2018 5.87 Million AUD 22.61%
2017 4.79 Million AUD 151.12%
2016 1.9 Million AUD 362.63%
2015 412.7 Thousand AUD 7.64%
2014 383.42 Thousand AUD 3.58%
2013 370.15 Thousand AUD 0.0%

Peer Operating Expenses Comparison of AdAlta Limited

Name Operating Expenses Operating Expenses Difference
EZZ Life Science Holdings Limited 39.57 Million AUD 82.894%
Anatara Lifesciences Ltd 710.21 Thousand AUD -853.161%
Zelira Therapeutics Limited 5.94 Million AUD -13.802%
Biome Australia Limited 7.91 Million AUD 14.432%
Patrys Limited 4.93 Million AUD -37.22%
Orthocell Limited 15.36 Million AUD 55.955%
Imugene Limited 135.09 Million AUD 94.989%
Noxopharm Limited 7 Million AUD 3.295%
PYC Therapeutics Limited 60.91 Million AUD 88.887%
Chimeric Therapeutics Limited 19.76 Million AUD 65.754%
Prescient Therapeutics Limited 10.89 Million AUD 37.887%
Proteomics International Laboratories Limited 892.14 Thousand AUD -658.792%
Cynata Therapeutics Limited 11.12 Million AUD 39.143%
CSL Limited 7.56 Billion AUD 99.91%
Arovella Therapeutics Limited 10.78 Million AUD 37.234%
Bio-Gene Technology Limited 2.76 Million AUD -145.182%
Clinuvel Pharmaceuticals Limited 31.29 Million AUD 78.37%
Starpharma Holdings Limited 22.81 Million AUD 70.33%
Nanollose Limited 12.5 Thousand AUD -54051.732%
Memphasys Limited 3.67 Million AUD -84.035%
Invex Therapeutics Ltd 3.34 Million AUD -102.324%
NeuroScientific Biopharmaceuticals Limited 1.96 Million AUD -244.465%
Amplia Therapeutics Limited 8.43 Million AUD 19.752%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD -1024.839%
Island Pharmaceuticals Limited 4.12 Million AUD -64.095%
Race Oncology Limited 14.77 Million AUD 54.169%
Nyrada Inc. 4.55 Million AUD -48.612%
Telix Pharmaceuticals Limited 269.26 Million AUD 97.486%
Dimerix Limited 25.64 Million AUD 73.601%
PharmAust Limited 6.65 Million AUD -1.69%
Immutep Limited 42.87 Million AUD 84.211%
Clarity Pharmaceuticals Ltd 56.3 Million AUD 87.978%
Alterity Therapeutics Limited 23.4 Million AUD 71.079%
BTC Health Limited -1.03 Million AUD 751.586%
Acrux Limited 8.55 Million AUD 20.824%
Neuren Pharmaceuticals Limited 32.69 Million AUD 79.296%
Biotron Limited 5.11 Million AUD -32.458%
Tissue Repair Ltd 6.66 Million AUD -1.54%
Radiopharm Theranostics Limited 299.22 Thousand AUD -2162.324%
Hexima Limited 1 Million AUD -571.079%
AnteoTech Limited 12.18 Million AUD 44.453%
Paradigm Biopharmaceuticals Limited 65.1 Million AUD 89.602%
Recce Pharmaceuticals Ltd 21.68 Million AUD 68.782%
Avecho Biotechnology Limited 4.54 Million AUD -48.931%
Actinogen Medical Limited 22.77 Million AUD 70.271%
Immuron Limited 9.13 Million AUD 25.918%
Argenica Therapeutics Limited 8.26 Million AUD 18.135%